Pera M, Trastek V F, Carpenter H A, Allen M S, Deschamps C, Pairolero P C
Department of Surgery, Mayo Clinic, Rochester, Minnesota.
Ann Thorac Surg. 1992 Aug;54(2):199-204. doi: 10.1016/0003-4975(92)91370-o.
Between 1982 and 1991, 19 patients (17 men and 2 women) with Barrett's esophagus, 10 of whom were in a surveillance program, were found to have high-grade dysplasia without evidence of invasive carcinoma. Median age was 66 years (range, 30 to 79 years). Heartburn was the most common presenting symptom. Esophagoscopy at the time of high-grade dysplasia diagnosis demonstrated normal Barrett's mucosa in 10 patients (53%), shallow ulcers in 3, slight mucosal irregularities in 2, small mucosal nodules in 2, stricture in 1, and shallow ulcer with stricture in 1. Eighteen patients underwent esophagectomy. There were no operative deaths. Nine patients (50%) had invasive carcinoma. Postsurgical stage was stage 0 in 9 patients, stage I in 6, stage IIA in 2, and stage IIB in 1. Median follow-up was 34 months (range, 2 to 116 months). Recurrent cancer developed in 2 patients. Overall 5-year survival was 66.7%; 5-year survival for patients with stage 0 disease was 100% and for stage I and II disease, 35.7%. We conclude that high-grade dysplasia in an indication for esophageal resection because of the high rate of associated early invasive carcinoma and that resection can be done safely with the expectation of excellent long-term survival. Because of these findings, we continue to recommend endoscopic surveillance in all patients with Barrett's esophagus.
1982年至1991年间,19例巴雷特食管患者(17例男性,2例女性)被发现存在高级别异型增生,且无浸润性癌证据,其中10例处于监测项目中。中位年龄为66岁(范围30至79岁)。烧心是最常见的首发症状。高级别异型增生诊断时的食管镜检查显示,10例患者(53%)的巴雷特黏膜正常,3例有浅溃疡,2例有轻微黏膜不规则,2例有小黏膜结节,1例有狭窄,1例有浅溃疡伴狭窄。18例患者接受了食管切除术。无手术死亡病例。9例患者(50%)有浸润性癌。术后分期为0期9例,I期6例,IIA期2例,IIB期1例。中位随访时间为34个月(范围2至116个月)。2例患者出现复发癌。总体5年生存率为66.7%;0期疾病患者的5年生存率为100%,I期和II期疾病患者为35.7%。我们得出结论,由于高级别异型增生合并早期浸润性癌的发生率高,它是食管切除的指征,并且切除可以安全进行,预期长期生存率良好。基于这些发现,我们继续建议对所有巴雷特食管患者进行内镜监测。